Does Finerenone (nonsteroidal mineralocorticoid receptor antagonist) affect Cardiovascular Risk?

Short answer

Current evidence does not establish a clear direction of effect for Cardiovascular Risk with Finerenone (nonsteroidal mineralocorticoid receptor antagonist).